AbbVie Inc.
US ˙ NYSE ˙ US00287Y1091

SecurityABBV / AbbVie Inc.
InstitutionAvestar Capital, LLC
Latest Disclosed Ownership14,762 shares
Latest Disclosed Value $ 3,210,667
Avestar Capital, LLC reports 0.31% increase in ownership of ABBV / AbbVie Inc.

On May 13, 2026 - Avestar Capital, LLC filed a 13F-HR form disclosing ownership of 14,762 shares of AbbVie Inc. (US:ABBV) valued at $3,210,587 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 14,717 shares of AbbVie Inc.. This represents a change in shares of 0.31% during the quarter. The current value of the position is $3,205,273 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F ABBVIE COM 00287Y109 14,762 45 0.31 3,211 -4.52 0.2062
2026-02-10 2025-12-31 13F ABBVIE COM 00287Y109 14,717 245 1.69 3,363 0.33 0.2179
2025-11-07 2025-09-30 13F ABBVIE COM 00287Y109 14,472 -1,246 -7.93 3,351 14.88 0.2194
2025-08-13 2025-06-30 13F ABBVIE COM 00287Y109 15,718 2,197 16.25 2,918 2.97 0.1993
2025-05-14 2025-03-31 13F ABBVIE COM 00287Y109 13,521 655 5.09 2,833 23.93 0.2460
2025-01-29 2024-12-31 13F ABBVIE COM 00287Y109 12,866 1,413 12.34 2,286 1.11 0.1943
2024-11-13 2024-09-30 13F ABBVIE COM 00287Y109 11,453 -33 -0.29 2,262 14.77 0.2327
2024-08-08 2024-06-30 13F ABBVIE COM 00287Y109 11,486 868 8.17 1,970 1.91 0.2023
2024-05-10 2024-03-31 13F ABBVIE COM 00287Y109 10,618 1,834 20.88 1,934 42.03 0.2028
2024-02-12 2023-12-31 13F ABBVIE COM 00287Y109 8,784 1,328 17.81 1,361 22.50 0.1543
2023-10-20 2023-09-30 13F ABBVIE COM 00287Y109 7,456 1,916 34.58 1,111 48.93 0.1581
2023-08-02 2023-06-30 13F ABBVIE COM 00287Y109 5,540 -1,601 -22.42 746 -34.45 0.1196
2023-04-20 2023-03-31 13F ABBVIE COM 00287Y109 7,141 738 11.53 1,138 10.06 0.2030
2023-01-20 2022-12-31 13F ABBVIE COM 00287Y109 6,403 684 11.96 1,035 34.64 0.1873
2022-10-26 2022-09-30 13F ABBVIE COM 00287Y109 5,719 28 0.49 768 -11.93 0.1957
2022-07-28 2022-06-30 13F ABBVIE COM 00287Y109 5,691 554 10.78 872 4.68 0.2147
2022-04-26 2022-03-31 13F ABBVIE COM 00287Y109 5,137 991 23.90 833 48.48 0.1329
2022-02-01 2021-12-31 13F ABBVIE COM 00287Y109 4,146 -89 -2.10 561 22.76 0.0686
2021-11-09 2021-09-30 13F ABBVIE COM 00287Y109 4,235 -3,979 -48.44 457 -50.59 0.0584
2021-08-03 2021-06-30 13F ABBVIE COM 00287Y109 8,214 -882 -9.70 925 -9.14 0.1240
2021-05-03 2021-03-31 13F ABBVIE COM 00287Y109 9,096 923 11.29 1,018 16.21 0.2271
2021-02-01 2020-12-31 13F ABBVIE COM 00287Y109 8,173 648 8.61 876 38.83 0.2432
2020-10-29 2020-09-30 13F ABBVIE COM 00287Y109 7,525 -2,358 -23.86 631 -34.95 0.2080
2020-07-29 2020-06-30 13F ABBVIE COM 00287Y109 9,883 2,423 32.48 970 70.77 0.4286
2020-05-12 2020-03-31 13F ABBVIE COM 00287Y109 7,460 4,401 143.87 568 110.37 0.3103
2020-02-14 2019-12-31 13F ABBVIE COM 00287Y109 3,059 -331 -9.76 270 5.06 0.1525
2019-11-15 2019-09-30 13F/A-1 ABBVIE INC COM USD0.01 COM 00287Y109 3,390 1,100 48.03 257 60.63 0.1598
2019-11-14 2019-09-30 13F ABBVIE INC COM USD0.01 COM 00287Y109 3,390 1,100 257 0.1598
2019-08-06 2019-06-30 13F ABBVIE INC COM USD0.01 COM 00287Y109 2,290 130 6.02 160 -4.76 0.1014
2019-05-09 2019-03-31 13F ABBVIE INC COM USD0.01 COM 00287Y109 2,160 566 35.51 168 17.48 0.1103
2019-01-25 2018-12-31 13F ABBVIE INC COM USD0.01 COM 00287Y109 1,594 -486 -23.37 143 -25.13 0.0977
2018-10-23 2018-09-30 13F ABBVIE INC COM USD0.01 COM 00287Y109 2,080 303 17.05 191 20.89 0.1104
2018-08-10 2018-06-30 13F ABBVIE INC COM USD0.01 COM 00287Y109 1,777 27 1.54 158 -1.86 0.0999
2018-05-10 2018-03-31 13F ABBVIE INC COM USD0.01 COM 00287Y109 1,750 -223 -11.30 161 -12.50 0.1047
2018-02-14 2017-12-31 13F ABBVIE INC COM USD0.01 COM 00287Y109 1,973 1,973 184 0.1375
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.